Topics

Articles

US total reaches $291.5 billion; dispensed prescriptions up 0.9%

2008 Market Summary From IMS Health: US Pharma Sales Up 1.3%, the Lowest in Decades

Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy

Stem Cell Therapy: Business Models Begin to Take Shape

Although beset by less-than-friendly federal reimbursement policies, independent pharmacies are maintaining their viability for pharmaceutical delivery

Independent Pharmacies Promote the Value of Their Patient Contact to the Pharma Industry

Higher complexity—and expense—are the reality for most drug research, says Tufts

Long-Term Drug Approval Trends Highlight the Industry's Productivity Dilemma

Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity

Novartis Managed Care Report Finds Higher Barriers to Drug Access

New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics

Business and Finance